Johnson & Johnson (JNJ)
Johnson & Johnson Book Value: 61.37B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
JNJ Book Value Rankings
| Overall | 98th percentile | 45 of 4391 |
| Sector | 99th percentile | 3 of 504 in Healthcare |
| Industry | 88th percentile | 3 of 25 in Drug Manufacturers - Major |
JNJ Book Value Range, Past 5 Years
| Minimum | 42.51B | Dec 2008 |
| Maximum | 62.13B | Jun 2011 |
| Average | 51.15B |
About Book Value of Equity
YCharts' book value of equity is equivalent to total assets less total liabilities. It includes all common and preferred equity.
Learn More
You may also be interested in these JNJ related companies
JNJ News
$JNJ 62.5x puts alerted last week at .72 before its drug news. Really killed the premium, just alerted to sell at .84. Small 16.7% gain.
about 5 hours ago by OptionRunners
about 5 hours ago by OptionRunners
Still a Bear Market http://stks.co/41w6 $CSCO $INTC $HPQ $IBM $JNJ $JPM
about 7 hours ago by LouisEbner
about 7 hours ago by LouisEbner
$JNJ broke the horizontal support, but within acceptable distance. V light maybe possible uptick is within a reach
about 22 hours ago by woowtrading
about 22 hours ago by woowtrading
J&J (JNJ) Receives FDA Warning Letter Related to K-Y Vaginal Moisturizer -WSJ
May 29, 1:57PM Street Insider
May 29, 1:57PM Street Insider
Five Stocks Hedge Funds are Betting Against: the Short List from Goldman Sachs http://stks.co/3zh7 $IBM $XOM $INTC $AMZN $JNJ
about 5 days ago by ycharts
about 5 days ago by ycharts
Current portfolio: $AAPL $AIG $JNJ $DD looking to add energy name soon
about 6 days ago by WestCoastHedge
about 6 days ago by WestCoastHedge
May 24 Support/resistance numbers for S&P and top components. http://stks.co/3y4b $ES_F $AAPL $XOM $CVX $JNJ $PG $$
about 6 days ago by TripleDTrader
about 6 days ago by TripleDTrader
Former Stryker (SYK) CEO Sends Strong Message to Other Execs: Ask First
May 23, 11:42AM Street Insider
May 23, 11:42AM Street Insider
Ex-Dividend Stocks http://stks.co/3wtm My story via @TheStreet $JNJ $MHP $AIZ $DNB $NDSN $WEP $SIX #Dividend #ExDividend
about 7 days ago by azendrian
about 7 days ago by azendrian
Go into Pharma to avoid the bloodbath in the markets. Rotation into safety $PFE $MRK $JNJ http://stks.co/3tbu
about 12 days ago by EPS_MomentuM
about 12 days ago by EPS_MomentuM
News related to $JNJ, currently 0.0% since open: 'Alkermes takes bigger 4Q loss after Elan deal' http://stks.co/3sOZ
about 13 days ago by TradeBot
about 13 days ago by TradeBot
Expectations Indicator triggered a Bear Market http://stks.co/3sJw $JNJ $JPM $KFT $MCD
about 13 days ago by LouisEbner
about 13 days ago by LouisEbner
RT @SeemaCnbc Cancer data expected to move big pharma $JNJ $PFE $AZN
about 13 days ago by StockTwits
about 13 days ago by StockTwits
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| JNJ | 62.21 | -0.38 | -0.61% | 171.83B |
| JMP | 5.87 | -0.05 | -0.84% | 130.60M |
| JMBA | 1.895 | -0.04 | -1.81% | 129.87M |
| JLS | 23.84 | -0.10 | -0.42% | |
| JLL | 72.17 | -2.07 | -2.79% | 3.239B |
| JKS | 3.91 | +0.01 | +0.26% | 87.20M |
| JKJ | 87.61 | -1.27 | -1.43% | |
| ISCA | 23.90 | -0.09 | -0.38% | 1.110B |
| ISBC | 14.76 | -0.24 | -1.60% | 1.672B |
| IRV | 21.82 | +0.45 | +2.11% |
